BNP Paribas Financial Markets’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$399K Buy
7,475
+2,389
+47% +$127K ﹤0.01% 2692
2025
Q1
$206K Sell
5,086
-3,396
-40% -$137K ﹤0.01% 2856
2024
Q4
$236K Sell
8,482
-12,220
-59% -$340K ﹤0.01% 2943
2024
Q3
$594K Sell
20,702
-8,370
-29% -$240K ﹤0.01% 2090
2024
Q2
$682K Sell
29,072
-30,222
-51% -$709K ﹤0.01% 1862
2024
Q1
$1.5M Sell
59,294
-152,918
-72% -$3.86M ﹤0.01% 1664
2023
Q4
$4.96M Buy
212,212
+152,691
+257% +$3.57M 0.01% 970
2023
Q3
$3.01M Buy
59,521
+24,047
+68% +$1.22M ﹤0.01% 1161
2023
Q2
$1.66M Sell
35,474
-29,043
-45% -$1.36M ﹤0.01% 1368
2023
Q1
$2.47M Buy
64,517
+26,757
+71% +$1.02M ﹤0.01% 1229
2022
Q4
$2.07M Buy
37,760
+23,142
+158% +$1.27M ﹤0.01% 1222
2022
Q3
$498K Sell
14,618
-7,780
-35% -$265K ﹤0.01% 2318
2022
Q2
$212K Buy
22,398
+15,817
+240% +$149K ﹤0.01% 2437
2022
Q1
$93.4K Buy
6,581
+885
+16% +$12.6K ﹤0.01% 2805
2021
Q4
$120K Buy
5,696
+898
+19% +$19K ﹤0.01% 2903
2021
Q3
$107K Buy
4,798
+3,857
+410% +$86.2K ﹤0.01% 2654
2021
Q2
$23.3K Sell
941
-781
-45% -$19.4K ﹤0.01% 2899
2021
Q1
$50K Buy
1,722
+393
+30% +$11.4K ﹤0.01% 3043
2020
Q4
$34.3K Sell
1,329
-1,752
-57% -$45.2K ﹤0.01% 3052
2020
Q3
$94.9K Buy
3,081
+2,651
+617% +$81.6K ﹤0.01% 2530
2020
Q2
$10.7K Sell
430
-2,045
-83% -$51K ﹤0.01% 3051
2020
Q1
$52.5K Buy
2,475
+1,913
+340% +$40.6K ﹤0.01% 2904
2019
Q4
$12.5K Sell
562
-42
-7% -$932 ﹤0.01% 3431
2019
Q3
$13.7K Buy
+604
New +$13.7K ﹤0.01% 3447